^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    CDK4 overexpression

    i
    Other names: CDK4, PSK-J3, Cyclin-dependent kinase 4
    Entrez ID:
    1019
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    Apply
    Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. (PalboSarc) (NCT03242382)
    Phase 2
    Grupo Espanol de Investigacion en Sarcomas
    Recruiting
    Last update posted :
    01/23/2024
    Initiation :
    03/31/2017
    Primary completion :
    09/30/2024
    Completion :
    09/30/2024
    CDKN2A • CDK4
    |
    CDKN2A mutation • CDK4 overexpression
    |
    Ibrance (palbociclib)
    A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET) (PALBONET) (NCT02806648)
    Phase 2
    Grupo Espanol de Tumores Neuroendocrinos
    Completed
    Last update posted :
    01/23/2018
    Initiation :
    05/01/2015
    Primary completion :
    07/01/2017
    Completion :
    01/01/2018
    RB1 • CCND1 • CDK4 • CDK6
    |
    CCND1 overexpression • CDK4 overexpression • RB1 overexpression • CDK6 expression
    |
    Ibrance (palbociclib)